drugset / Trial / NCT00210535
A Study of the Effectiveness and Safety of Topiramate for the Prevention of Migraine Attacks in Children
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary purpose of this study is to evaluate the effectiveness and safety of topiramate compared with placebo in the prevention of migraine attacks in children (12 to 17 years of age).
Timeline
- Start
- 2005-06
- Primary completion
- —
- Completion
- 2006-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Topiramate | Small molecule | 50 mg | — |
| Subject | Topiramate | Small molecule | 100 mg | — |